Internal Medicine, Cardiovascular Disease · Saint Louis, MO
NPI
1104822014
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
10012 Kennerly Rd, Ste 300
Saint Louis, MO, 63128
Phone (314) 842-0602
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
3,473 services
Medicare patients, 2024
1,642
Average age 77
Drug cost, 2024
$3.0M
12,921 prescriptions
Company payments, 2025
$1,050
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles F Carey was code 99214 (office e&m - established), 761 times for 587 patients. In total Charles F Carey billed 3,473 services in 56 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 761 | 587 | $85.67 | $65K |
| 93010 Electrocardiogram | Facility | 406 | 387 | $5.53 | $2,243 |
| 93000 Electrocardiogram | Office | 385 | 335 | $9.49 | $3,655 |
| 93306 Echocardiography (TTE/TEE) | Facility | 316 | 315 | $47.98 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 156 | 80 | $58.64 | $9,147 |
| 93325 Echocardiography (TTE/TEE) | Facility | 122 | 115 | $2.24 | $274 |
| 93016 Electrocardiogram | Facility | 118 | 117 | $14.99 | $1,769 |
| 99223 Hospital E&M - Initial | Facility | 111 | 106 | $131.90 | $15K |
| 93018 Electrocardiogram | Facility | 102 | 101 | $10.01 | $1,021 |
| 78452 Myocardial Perfusion Scan | Facility | 100 | 100 | $52.85 | $5,285 |
| 93320 Echocardiography (TTE/TEE) | Facility | 80 | 77 | $12.99 | $1,039 |
| 99233 Hospital E&M - Subsequent | Facility | 77 | 49 | $89.05 | $6,857 |
| 93264 External Electrocardiographic Monitoring | Office | 65 | 23 | $39.22 | $2,549 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 58 | 57 | $12.60 | $731 |
| 99204 Office E&M - New | Office | 54 | 54 | $114.77 | $6,198 |
By year: 2022 $184K for 3,944 services; 2023 $184K for 3,842 services; 2024 $168K for 3,473 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles F Carey prescribed most often to Medicare patients was Metoprolol Succinate, with 1,003 prescriptions and refills. In total Charles F Carey wrote 12,921 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,003 | 2,651 | 278 | $13K |
| Ezetimibe Generic | 990 | 2,792 | 285 | $22K |
| Eliquis Apixaban | 944 | 1,909 | 216 | $1.1M |
| Rosuvastatin Calcium Generic | 940 | 2,679 | 263 | $11K |
| Atorvastatin Calcium Generic | 906 | 2,526 | 255 | $9,633 |
| Torsemide Generic | 849 | 2,104 | 266 | $16K |
| Spironolactone Generic | 730 | 2,009 | 234 | $4,896 |
| Amlodipine Besylate Generic | 555 | 1,553 | 162 | $3,301 |
| Metoprolol Tartrate Generic | 554 | 1,584 | 160 | $4,782 |
| Digoxin Generic | 403 | 1,107 | 126 | $7,254 |
| Carvedilol Generic | 386 | 1,071 | 107 | $4,922 |
| Clopidogrel Clopidogrel Bisulfate | 364 | 1,004 | 114 | $4,360 |
| Entresto Sacubitril/Valsartan | 360 | 743 | 97 | $399K |
| Farxiga Dapagliflozin Propanediol | 336 | 608 | 86 | $327K |
| Lisinopril Generic | 325 | 933 | 97 | $2,051 |
Brand drugs: 2,592 claims; generic drugs: 10,329 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles F Carey $1,050 ($1,050 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbott Laboratories with $604.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 14 | $604 |
| Boston Scientific Corporation BSX | 2 | $164 |
| Pfizer Inc. PFE | 3 | $68.94 |
| CVRx, Inc. CVRX | 2 | $62.52 |
| Merck Sharp & Dohme LLC MRK | 2 | $37.67 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.94 |
| Scpharmaceuticals Inc. SCPH | 1 | $25.84 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $19.53 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.79 |
| Esperion Therapeutics, Inc. ESPR | 1 | $13.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.